ASM Leads Stakeholder Letter Urging a Review of COVID-19 Response to Prepare for Future Pandemics

March 30, 2020

On March 30, ASM and partners submitted the below letter to House appropriators calling for a high-level, comprehensive review of the COVID-19 response once the immediate public health emergency subsides in order to plan for future pandemics. ASM also submitted an identical letter to Senate appropriators.

Dear Chair Lowey, Ranking Member Granger, Chair DeLauro and Ranking Member Cole:

We, the undersigned organizations representing millions of individuals working to address the unprecedented challenges SARS-CoV-2 has presented to our society, our healthcare system, and our economy, are committed to working with Congress and the Administration to address the pressing needs associated with the novel coronavirus (SARS-CoV-2) and COVID-19.

We are writing to request that, as soon as the immediate public health emergency subsides, Congress and the Administration initiate a high-level, comprehensive review of the COVID-19 response through either a federal commission or a qualified, nonpartisan entity such as the National Academies of Science, Engineering, and Medicine. This process should also be forward-looking and make cross-cutting recommendations on how the United States can better prepare for future public health emergencies, including funding needs and policy changes. By fully understanding what went well and what did not during this most recent pandemic, we can help thwart, or at the very least minimize, the effects of the next pandemic.

Specifically, such a review should recommend the most effective ways to:
  • Ensure coordination and collaboration across and amongst federal agencies and with state and local authorities;
  • Clearly and effectively communicate practical, science-based information and guidance to stakeholder entities and to the public;
  • Build public health capacity, including at the local, state and tribal health department levels;
  • Rapidly scale up laboratory testing capacity in order to get tests to those who need them;
  • Ensure a steady supply chain of materials to labs, clinics, hospitals and workplaces to mitigate shortages;
  • Protect the most vulnerable in our communities by reducing patient access barriers to testing and health care services; and
  • Facilitate global collaboration to ensure that responses are based on real-time, accurate information.
The current crisis has brought to light a number of barriers, challenges and shortcomings in our ability to handle a public health emergency. Some of these were the results of “real-time” decision-making, while others exposed systemic breakdowns that were years – if not decades – in the making. These cut across multiple agencies and span levels of government from federal, to state, to local authorities.

While public health professionals, health departments, clinical laboratories, clinics and hospitals have the most immediate connection to the current crisis, a comprehensive, well-planned approach will be critical to a long-term strategy to head off future pandemics. A comprehensive approach includes medical research and development, social, behavioral and economic considerations, corporate partners to ensure product and service delivery, small businesses, universities and research institutions, as well as healthcare professions.

We stand ready to work with you to help improve the systems we have in place today, and to develop the solutions that will help address tomorrow’s challenges.


1,000 Days
American Academy of Pediatrics
American Association for Clinical Chemistry
American Association for the Advancement of Science
American Association of Colleges of Pharmacy
American Association of Immunologists
American Institute for Medical and Biological Engineering
American Public Health Association
American Society for Clinical Pathology
American Society for Microbiology
American Society for Nutrition
American Society for Pharmacology and Experimental Therapeutics
American Society for Virology
American Society of Hematology
American Society of Tropical Medicine and Hygiene
Association for Professionals in Infection Control and Epidemiology
Association of American Cancer Institutes
Association of American Universities
Association of Maternal & Child Health Programs
Association of Population Centers
Association of Public Health Laboratories
Association of Public and Land-grant Universities
Biophysical Society
Coalition for the Life Sciences
Federation of Associations in Behavioral & Brain Sciences
Foundation for Vaccine Research
Global Health Technologies Coalition
Infectious Diseases Society of America
National Association of County and City Health Officials
National Safety Council
OSA, The Optical Society
Population Association of America
Society of Infectious Diseases Pharmacists
Susan G. Komen
The Society for Healthcare Epidemiology of America
Trust for America’s Health
Vaccinate Your Family

Author: ASM Advocacy

ASM Advocacy
ASM Advocacy is making it easy and providing opportunities for members to advocate for evidence-based scientific policy.